Severe infections in patients with ANCA associated vasculitis treated with rituximab

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

Ann Rheum Dis.

Smith RM, Jones RB, Specks U, Bond S, Nodale M, Aljayyousi R, Andrews J, Bruchfeld A, Camilleri B, Carette S, Cheung CK, Derebail V, Doulton T, Forbess L, Fujimoto S, Furuta S, Gewurz-Singer O, Harper L, Ito-Ihara T, Khalidi N, Klocke R, Koening C, Komagata Y, Langford C, Lanyon P, Luqmani RA, Makino H, McAlear C, Monach P, Moreland LW, Mynard K, Nachman P, Pagnoux C, Pearce F, Peh CA, Pusey C, Ranganathan D, Rhee RL, Spiera R, Sreih AG, Tesar V, Walters G, Weisman MH, Wroe C, Merkel P, Jayne D, RITAZAREM coinvestigators., RITAZAREM co-investigators

doi: 10.1136/annrheumdis-2019-216863.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Disease Activity, ANCA-Type, and Lipid Levels in ANCA-Associated Vasculitis

Arthritis Rheumatol.

Wallace ZS, Fu X, Liao K, Kallenberg CGM, Langford CA, Merkel PA, Monach P, Seo P, Specks U, Spiera R, St Clair EW, Zhang Y, Choi H, Stone JH

doi: 10.1002/art.41006.

Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials

J Am Acad Dermatol.

Fleming P, Drucker AM

doi: 10.1016/j.jaad.2017.09.052.

Melanoma and Skin Cancer

Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene

JAMA Dermatol.

Cabello I, Alia P, Pintó X, Muniesa C, Fernandez-de-Misa R, Peñate Y, Morillo M, Perez-Farriols A, Estrach T, Izu R, Gallardo F, Román C, Cervigón I, Ortiz-Brugues A, Ortiz-Romero PL, Servitje O

doi: 10.1001/jamadermatol.

Psoriasis

Association of Patient Mental Health Status With the Level of Agreement Between Patient and Physician Ratings of Psoriasis Severity

JAMA Dermatol

Carr E, Mahil SK, Brailean A, Dasandi T, Pink AE, Barker JN, Rayner L, Turner MA, Goldsmith K, Smith CH

doi: 10.1001/jamadermatol.2020.5844

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

Ann Rheum Dis.

Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalçındağ N, Jayne DR, Mukhtyar C

doi: 10.1136/

Psoriasis

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Br J Dermatol.

Yiu ZZN, Ashcroft DM, Evans I, McElhone K, Lunt M, Smith CH, Walton S, Murphy R, Reynolds NJ, Ormerod AD, Griffiths CEM, Warren RB; BADBIR Study Group

doi: 10.1111/bjd.17036.

Further Publications Rheumatology

Valvular and infection-associated risk factors as criteria to guide the use of echocardiography in patients with native joint infections

Semin Arthritis Rheum

Beaufrère M, Pressat-Laffouilhère T, Marcelli C, Michon J, Lequerré T, Prum-Delépine C, Fiaux E, Rasoldier V, Etienne M, Savouré A, Dormoy L, Dargère S, Verdon R, Vittecoq O, Avenel G

doi: 10.1016/j.semarthrit.2021.08.008

Rheumatoid Arthritis

Rheumatic manifestations associated with Chikungunya virus infection: A study of 307 patients with 32-month follow-up (RHUMATOCHIK study)

Joint Bone Spine.

Bouquillard E, Fianu A, Bangil M, Charlette N, Ribéra A, Michault A, Favier F, Simon F, Flipo RM

doi: 10.1016/j.jbspin.2017.01.014.

Related content